Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.


A placebo-controlled, comparative clinical study was conducted to test the hypothesis that nicotinic acid as an adjuvant medication has a beneficial therapeutic effect over and above the effect which can be achieved by the administration of phenothiazine drugs alone, over a six-month period, in newly (recently) admitted schizophrenic patients.The most… (More)


  • Presentations referencing similar topics